Suppr超能文献

直肠转移性鳞状细胞癌肝转移的积极治疗:一例报告并文献简要回顾

Aggressive treatment of metastatic squamous cell carcinoma of the rectum to the liver: a case report and a brief review of the literature.

作者信息

Theodosopoulos Theodosios K, Marinis Athanasios D, Dafnios Nikolaos A, Vassiliou John G, Samanides Lazaros D, Carvounis Eleni E, Smyrniotis Vassilios E

机构信息

Second Department of Surgery, Areteion University Hospital, Athens Medical School, University of Athens, 76 Vasilisis Sofias av, 11528, Athens, Greece.

出版信息

World J Surg Oncol. 2006 Aug 8;4:49. doi: 10.1186/1477-7819-4-49.

Abstract

BACKGROUND

Rectal squamous cell carcinoma (SCC) is a rare tumor. The incidence of this malignancy has been reported to be 0.25 to 1 per 1000 colorectal carcinomas. From a review of the English literature 55 cases of SCC of the rectum have been published. In this study we report a rectal metastatic SCC to the liver, discussing the efficacy of aggressive adjuvant and neo-adjuvant therapies on survival and prognosis.

CASE PRESENTATION

A 39-year-old female patient with a pure SCC of the rectum diagnosed endoscopically is presented. The patient underwent initially neoadjuvant chemo-radiotherapy and then abdominoperineal resection with concomitant bilateral oophorectomy and hysterectomy, followed by adjuvant chemo-radiotherapy. Five months after the initial operation liver metastasis was demonstrated and a liver resection was carried out, followed by adjuvant chemotherapy. Eighteen months after the initial operation the patient is alive.

CONCLUSION

Although prognosis of rectal SCC is worse than that of adenocarcinoma, an aggressive therapeutic approach with surgery as the primary treatment, followed by combined neo- and adjuvant chemo-radiotherapy, may be necessary in order to improve survival and prognosis.

摘要

背景

直肠鳞状细胞癌(SCC)是一种罕见肿瘤。据报道,这种恶性肿瘤在每1000例结直肠癌中的发病率为0.25至1例。通过对英文文献的回顾,已发表了55例直肠SCC病例。在本研究中,我们报告了一例直肠SCC肝转移病例,并讨论积极的辅助和新辅助治疗对生存和预后的疗效。

病例介绍

本文介绍了一名39岁女性患者,经内镜诊断为单纯直肠SCC。该患者最初接受新辅助放化疗,然后行腹会阴联合切除术,同时双侧卵巢切除术和子宫切除术,随后进行辅助放化疗。初次手术后五个月发现肝转移,遂行肝切除术,随后进行辅助化疗。初次手术后18个月,患者仍存活。

结论

尽管直肠SCC的预后比腺癌差,但为了提高生存率和改善预后,可能需要采取以手术为主的积极治疗方法,随后联合新辅助和辅助放化疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67e6/1555584/9815367777c5/1477-7819-4-49-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验